Side-by-side comparison of AI visibility scores, market position, and capabilities
BrightInsight is the leading global regulated digital health platform for biopharma and medtech; raised $166M total (Series C $101M led by General Catalyst in 2021); supports SaMD, connected devices, and disease management programs.
BrightInsight is a digital health infrastructure company that provides the leading global regulated platform for biopharma and medtech companies building Software as a Medical Device (SaMD) and connected health programs. Founded in 2017 by Kal Patel, a former Bristol-Myers Squibb executive, BrightInsight is headquartered in San Jose, California. The company's platform captures, transmits, and analyzes data from FDA-regulated and CE-marked medical devices, combination products, digital therapeutics, and companion apps — all while maintaining compliance with HITRUST, GDPR, FDA 21 CFR Part 11, IEC 62304, and other regulatory frameworks. This regulated-by-design infrastructure layer eliminates the need for biopharma and medtech companies to build compliant digital health backends from scratch.
Zocdoc is a patient appointment booking marketplace that lets patients find and book in-network doctors in real time, with insurance verification and same-day availability filters.
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Patients can filter by specialty, insurance plan, location, and next available appointment, then book online in seconds — eliminating the phone-tag and hold-time historically required to schedule care. The platform verifies insurance acceptance in real time and sends automated reminders to reduce no-shows.
BrightInsight vs
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.